![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Karger
E-ISSN: 1421-9794|47|2|109-126
ISSN: 0009-3157
Source: Chemotherapy, Vol.47, Iss.2, 2001-03, pp. : 109-126
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Pharmacology, Vol. 85, Iss. 4, 2010-04 ,pp. :
![](/images/ico/o.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Gastrointestinal Cancer Refractory to Chemotherapy: A Role for Octreotide?
Chemotherapy, Vol. 47, Iss. 2, 2001-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Future Prospects for Luteinizing Hormone-Releasing Hormone Analogues in Prostate Cancer Treatment
Pharmacology, Vol. 85, Iss. 2, 2010-02 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
The Palliative Effects of Octreotide in Cancer Patients
Chemotherapy, Vol. 47, Iss. 2, 2001-03 ,pp. :